Stockscreener 앱 받기
12.57
5.06%
-0.67
시간 외 거래:
12.75
0.18
+1.43%
전일 마감가:
$13.24
열려 있는:
$13.32
하루 거래량:
2.53M
Relative Volume:
1.22
시가총액:
$849.35M
수익:
$796.00M
순이익/손실:
$-136.49M
주가수익비율:
-6.0144
EPS:
-2.09
순현금흐름:
$-64.24M
1주 성능:
+2.44%
1개월 성능:
+15.43%
6개월 성능:
-39.04%
1년 성능:
-71.72%
1일 변동 폭
$12.55
$13.52
1주일 범위
$12.01
$13.52
52주 변동 폭
$9.98
$47.60
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
명칭
Tandem Diabetes Care Inc
전화
858-366-6900
주소
12400 HIGH BLUFF DRIVE, San Diego, CA
TNDM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
12.57 | 894.62M | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
136.04 | 234.21B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
97.83 | 145.55B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
376.83 | 144.45B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
95.08 | 122.61B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
74.41 | 43.77B | 5.69B | 1.41B | 577.90M | 6.95 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-08 | 개시 | Oppenheimer | Outperform |
| 2025-08-12 | 업그레이드 | Citigroup | Sell → Neutral |
| 2025-08-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-07-09 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2025-06-16 | 개시 | Truist | Hold |
| 2025-04-10 | 개시 | Mizuho | Neutral |
| 2025-03-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-03-03 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | 개시 | Bernstein | Outperform |
| 2024-10-04 | 개시 | Goldman | Neutral |
| 2024-10-02 | 개시 | RBC Capital Mkts | Outperform |
| 2024-08-22 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-08-08 | 개시 | Canaccord Genuity | Buy |
| 2024-05-30 | 개시 | Redburn Atlantic | Buy |
| 2024-05-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-04-29 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | 업그레이드 | Stifel | Hold → Buy |
| 2023-08-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-05-05 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-04-24 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-01-26 | 개시 | Wolfe Research | Peer Perform |
| 2022-11-15 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-08-09 | 다운그레이드 | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2022-01-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-25 | 개시 | Barclays | Underweight |
| 2020-12-15 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | 개시 | Wells Fargo | Overweight |
| 2020-07-31 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-07-06 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-06-18 | 재확인 | Raymond James | Outperform |
| 2020-04-24 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-06 | 개시 | Raymond James | Outperform |
| 2020-02-04 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | 개시 | Guggenheim | Buy |
| 2019-10-04 | 업그레이드 | UBS | Neutral → Buy |
| 2019-05-17 | 재확인 | BofA/Merrill | Neutral |
| 2019-05-13 | 개시 | SVB Leerink | Outperform |
| 2019-03-08 | 개시 | BMO Capital Markets | Outperform |
| 2019-03-05 | 재확인 | BofA/Merrill | Neutral |
| 2019-02-27 | 재확인 | Lake Street | Buy |
| 2018-11-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | 재확인 | Dougherty & Company | Buy |
| 2018-09-26 | 재확인 | Piper Jaffray | Overweight |
모두보기
Tandem Diabetes Care Inc 주식(TNDM)의 최신 뉴스
Aug Summary: Is Tandem Diabetes Care Incs growth already priced inDollar Strength & Weekly Market Pulse Updates - khodrobank.com
Tandem Diabetes Care, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your RightsTNDM - ACCESS Newswire
Growth Report: What is Tandem Diabetes Care Inc.’s valuation compared to sectorJuly 2025 Chart Watch & Comprehensive Market Scan Reports - khodrobank.com
Aug Spikes: Is MacKenzie Realty Capital Inc backed by strong institutional buyingMarket Performance Recap & Long Hold Capital Preservation Plans - khodrobank.com
Why Tandem Diabetes (TNDM) Stock Is Up Today - Yahoo Finance
United States Insulin Pump Market Expansion Driven by Diabetes - openPR.com
Aug Analyst Calls: Should value investors consider Tandem Diabetes Care IncWeekly Trend Recap & Daily Profit Maximizing Tips - خودرو بانک
Tandem Diabetes Care Announces Publication Showing Adults With Type 2 Diabetes Benefit from Automated Insulin Delivery Regardless of C-Peptide Levels - BioSpace
TNDM Investor News: If You Have Suffered Losses in Tandem - GlobeNewswire
Sell Signal: Is Tandem Diabetes Care Inc. stock risky to hold nowEarnings Performance Report & Capital Efficient Trade Techniques - khodrobank.com
Market Wrap: Whats the beta of Tandem Diabetes Care Inc stockJuly 2025 Setups & Technical Pattern Alert System - خودرو بانک
Tandem Diabetes (TNDM) Study Highlights Benefits of Control-IQ+ - GuruFocus
Tandem study- adults with type 2 diabetes benefit from automated insulin delivery, regardless of C-peptide levels - MarketScreener
Aug Patterns: Does Tandem Diabetes Care Inc. have strong fundamentalsPortfolio Value Report & Reliable Breakout Stock Forecasts - خودرو بانک
Acadian Asset Management LLC Takes Position in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Value Recap: Will Tandem Diabetes Care Inc stock benefit from M AEarnings Growth Summary & Risk Managed Trade Strategies - khodrobank.com
Earnings Recap: How is Tandem Diabetes Care Inc managing supply chain issues2025 Fundamental Recap & Safe Entry Point Identification - khodrobank.com
Diabetes warning issued over insulin pump error - MSN
Market Trends: Is Tandem Diabetes Care Incs growth already priced inJuly 2025 Pullbacks & Consistent Return Investment Signals - khodrobank.com
Fda Tandem Diabetes Care Issues Correction For Certain TSlim X2 Insulin Pumps - MarketScreener
Analysis Recap: Is Tandem Diabetes Care Inc part of any major indexBond Market & Consistent Profit Trading Strategies - خودرو بانک
Weekly Recap: Is Tandem Diabetes Care Inc forming bullish engulfing patternsJuly 2025 Institutional & Low Risk High Reward Trade Ideas - خودرو بانک
Top 3 Health Care Stocks That Are Preparing To Pump This Month - Sahm
Jim Cramer Calls Tandem Diabetes “Speculative Stock for Younger People” - Yahoo
Tandem Diabetes Care (NASDAQ:TNDM) Now Covered by Oppenheimer - MarketBeat
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights | Dow Theory Letters - FinancialContent
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Sees Significant Drop in Short Interest - MarketBeat
Jacobs Levy Equity Management Inc. Cuts Stock Position in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation – TNDM | FinancialContent - FinancialContent
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation – TNDM - The Joplin Globe
Edmond DE Rothschild Holding S.A. Makes New $4.84 Million Investment in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation – TNDM | Dow Theory Letters - FinancialContent
What data driven models say about Tandem Diabetes Care Inc.’s future2025 Pullback Review & Free Growth Oriented Trading Recommendations - Newser
Insulin pump makers Tandem and Insulet post contrasting Q2 results - MSN
Levi & Korsinsky Announces an Investigation on Behalf of Tandem Diabetes Care, Inc. (TNDM) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
Elliott Wave Theory Predicts Pullback in Tandem Diabetes Care Inc.2025 Market Outlook & Technical Confirmation Trade Alerts - beatles.ru
Sessa Capital IM L.P. Acquires Shares of 4,466,307 Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
RSI Crosses Above 30 for Tandem Diabetes Care Inc. — Reversal in SightJuly 2025 Intraday Action & Risk Adjusted Buy and Sell Alerts - beatles.ru
TNDM's Analyst Ratings: Oppenheimer Lowers Price Target by 50% | - GuruFocus
Oppenheimer Adjusts Tandem Diabetes Care Price Target to $22 From $44, Maintains Outperform Rating - MarketScreener
Oppenheimer maintains Tandem Diabetes Care stock rating, lowers price target - Investing.com Canada
Park West Asset Management LLC Cuts Holdings in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Take Care Before Jumping Onto Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Even Though It's 27% Cheaper - 富途牛牛
First Light Asset Management LLC Sells 46,860 Shares of Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Using Ichimoku Cloud for Tandem Diabetes Care Inc. technicals2025 Volatility Report & Weekly High Return Opportunities - Newser
Should you wait for a breakout in Tandem Diabetes Care Inc.July 2025 Highlights & Consistent Growth Stock Picks - Newser
Is Tandem Diabetes Care Inc. a strong candidate for buy and holdInflation Watch & Free Reliable Trade Execution Plans - خودرو بانک
How does Tandem Diabetes Care Inc. perform in inflationary periodsDay Trade & Safe Swing Trade Setups - خودرو بانک
Long term hold vs stop loss in Tandem Diabetes Care Inc.Fed Meeting & Proven Capital Preservation Methods - Newser
Tandem Diabetes Care shares rise 2.42% premarket after mobile app approval. - AInvest
Tandem Diabetes Care Inc (TNDM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.80%
1.23%
자본화:
|
볼륨(24시간):